Researchers from the Center for Regenerative Medicine (CReM) and the Department of Medicine at Boston Medical Center (BMC) ...

Scientists from Duke-NUS Medical School and their collaborators have identified an inherited genetic variation prevalent among East Asians that ...

Dr Tina Willits was given just 24 months to live after a cancer diagnosis. Against all odds, she's now in remission.

This represents the fourth indication granted a Breakthrough Device Designation for the SCD by FDADENVER, Nov. 06, 2024 (GLOBE NEWSWIRE) -- ...

Until now, CAR T-cell therapy here has been used only in cancer patients. But experts believe it could treat other diseases, ...

A new single-dose treatment demonstrates potential for improving heart repair following heart attacks in preclinical studies. Researchers at the Eli and Edythe Broad Center of Regenerative Medicine an ...

Jennifer Doudna, the co-developer of CRISPR, says there’s a “coming revolution” in climate-adapted crops and animals.

Researchers say the therapy is potentially transformative for those with a common form of advanced, aggressive breast cancer ...

In addition, Imugene has made strides in expanding its trial. The Cohort Review Committee has cleared the first cohort of ...

New Gene Therapy Approach Shows Promise for Duchenne Muscular Dystrophy July 24, 2024 — Researchers have made a significant breakthrough in developing a new gene therapy approach that restores ...

A new drug therapy for aggressive advanced breast cancer could potentially double the amount of time patients live without ...

A "groundbreaking" drug is being trialled in the first Brits to cure autoimmune conditions such as lupus and multiple ...